Skip to content
Scb logo white
Scb logo color
  • About
  • Platform
  • Programs
  • News
  • Careers
  • Contact

News

Picture website
News Release

Scenic Biotech and the Barth Syndrome Foundation Announce Partnership to Explore Genetic Modifiers to Find Tailored Treatment for the Complex Rare Disease

1. scenic biotech genetic modifier image 1
Announcement

Proof of concept in preclinical models for the use of QPCTL inhibition

Rene van den oever
News Release

Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases

Genbanner ecp green i
Coverage

Biocentury features an emerging company profile on Scenic Biotech

Biotrinity
Announcement

Sebastian Nijman presenting at BioTrinity 2021

Rene van den oever
Announcement

Scenic Biotech and Genentech expand their Genetic Modifier Partnership

Phillipe dro (1)
News Release

Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman

Ton schumacher
Announcement

Ton Schumacher, member of Scenic’s Scientific Advisory Board has been awarded the Jeantet-Collen Prize for Translational Medicine

1. scenic biotech genetic modifier image 1
Coverage

Scenic’s Chief Scientific Officer Sebastian Nijman explains why genetic modifiers are an untapped source of drug targets

Genentech
News Release

Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech

2. c5w4ahaxeaawkds
Announcement

Scenic founders publish paper in Science Signaling

Izeboud oscar 1200
News Release

Scenic Biotech Appoints Oscar Izeboud as Chief Executive Officer

ABOUT PLATFORM PROGRAMS NEWS CAREERS CONTACT

© Scenic Biotech 2021

Privacy Policy Disclaimer Cookies

Webdesign by Marsmedia


Twitter icon


Linkedin icon

Scb footer
Scb footer mob